• HMNC Brain Health

  Participated · Series B · Jun 2026

  HMNC Brain Health is developing orally available, precision therapies for depressive and other neuropsychiatric disorders. Its lead programs are Ketabon (KET01), an oral extended-release ketamine formulation that showed rapid antidepressant effects with reduced dissociative side effects in Phase 2 studies, and Nelivabon (BH-200), an oral vasopressin V1b receptor antagonist that delivered promising results in the Phase 2b OLIVE study using a proprietary genetic method for patient selection. Both candidates are in clinical development and not yet approved by regulators. The company plans to use the newly raised capital to support late-stage clinical development and to prepare Phase 3 programs for these assets. HMNC has entered a strategic licensing agreement granting MEDICE exclusive marketing rights for KET01 in Europe, with HMNC set to receive tiered double-digit royalties and milestone payments. The company is exploring expanding its programs to other neurological and psychiatric indications.

• Fliit

  Participated · Series A · Mar 2019

  fliit provides a technology platform used by more than 200 fresh food carriers and shippers to manage transportation and tours with improved capacity utilization, flexibility and transparency. The platform serves customers including MSG Frucht, L’Osteria, Rewe, Landgard and HelloFresh. Founded in 2016 and led by CEO Falvio Alario, the company operates primarily in Germany and nearby countries. fliit raised €10m in a Series A to fund product development and growth. The company plans to use the proceeds to develop its digital platform further and to begin international expansion. The business focuses on fresh food logistics and tour optimization for carriers and shippers. Fliit is a logistics platform focused on supplying fresh food and other sensitive products to customers. The company uses a provider management system to match the right supplier with each retailer and product and provides transparency through various tracking options. Its offering adapts logistics to differing product demands and individual customer delivery preferences. Flavio Alario is founder and CEO and has described the company’s approach as tailoring logistics individually for each product and customer. Fliit says it will use the new funding to continue its expansion. An investor described Fliit as building the operating system for the last mile applied to fresh food.

No current team members are available.